1. Home
  2. LOOP vs PMVP Comparison

LOOP vs PMVP Comparison

Compare LOOP & PMVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Loop Industries Inc.

LOOP

Loop Industries Inc.

HOLD

Current Price

$1.34

Market Cap

65.7M

Sector

Industrials

ML Signal

HOLD

Logo PMV Pharmaceuticals Inc.

PMVP

PMV Pharmaceuticals Inc.

HOLD

Current Price

$1.31

Market Cap

76.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LOOP
PMVP
Founded
2010
2013
Country
Canada
United States
Employees
N/A
N/A
Industry
Major Chemicals
Medicinal Chemicals and Botanical Products
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
65.7M
76.8M
IPO Year
2010
2020

Fundamental Metrics

Financial Performance
Metric
LOOP
PMVP
Price
$1.34
$1.31
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
47.4K
395.0K
Earning Date
05-28-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
27.27
N/A
EPS
N/A
N/A
Revenue
$10,889,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$174.82
N/A
P/E Ratio
N/A
N/A
Revenue Growth
7016.99
N/A
52 Week Low
$0.88
$0.85
52 Week High
$2.29
$1.88

Technical Indicators

Market Signals
Indicator
LOOP
PMVP
Relative Strength Index (RSI) 39.91 45.01
Support Level $1.20 $1.09
Resistance Level $1.37 $1.50
Average True Range (ATR) 0.08 0.08
MACD -0.01 -0.01
Stochastic Oscillator 12.59 32.20

Price Performance

Historical Comparison
LOOP
PMVP

About LOOP Loop Industries Inc.

Loop Industries Inc. is a technology and licensing company whose mission is to accelerate the world's shift toward sustainable plastic and away from dependence on fossil fuels. The company owns patented and proprietary technology that depolymerizes no and low value waste PET plastic and polyester fiber, including plastic bottles and packaging, carpet and polyester textile of any color, transparency or condition, and even ocean plastics that have been degraded by the sun and salt, to its base building blocks.

About PMVP PMV Pharmaceuticals Inc.

PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. The key product candidate, rezatapopt, is designed to be an orally available small molecule that structurally corrects the mutant p53 protein with the Y220C mutation. Currently, the product candidates are undergoing preclinical and clinical testing, and company relies on third parties for the manufacture after marketing approvals.

Share on Social Networks: